1. Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel. (2nd August 2021) Authors: Lotan, Itay; Wilf‐Yarkoni, Adi; Friedman, Yitzhak; Stiebel‐Kalish, Hadas; Steiner, Israel; Hellmann, Mark A. Journal: European journal of neurology Issue: Volume 28:Number 11(2021) Page Start: 3742 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗